• Quince Therapeutics set June 11, 2026 for virtual annual stockholder meeting via live webcast.
• Key vote covers charter amendment authorizing board to implement reverse stock split within 1-for-10 to 1-for-100 range.
• Other items include ratification of BDO USA as independent auditor for fiscal 2026.
• Stockholders will also cast advisory vote on named executive officer compensation.
• Meeting will also seek approval to adjourn or postpone session if needed to secure votes on proposals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quince Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-161838), on April 17, 2026, and is solely responsible for the information contained therein.